Product
Anti-(integrin beta-3) human monoclonal antibody
1 clinical trial
1 indication
Clinical trial
A Phase 2, Multicenter, Open-label Study to Evaluate the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a AlloimmunizationStatus: Not yet recruiting, Estimated PCD: 2027-05-01